Press Releases

Sep 07, 2022

New Data Suggest Veracyte’s Envisia Genomic Classifier Can Help Predict Disease Progression in Interstitial Lung Disease Patients Treated with Combination Immunosuppressive Therapy

Read More

Sep 01, 2022

Veracyte to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Read More

Aug 31, 2022

Veracyte Announces Seven Abstracts to Be Presented at ESMO Congress 2022

Read More

Aug 29, 2022

New Data in Nature Medicine Suggest Pre-Treatment Tumor Microenvironment Can Impact Response for CAR T-Cell Therapy in Patients with Large B-Cell Lymphoma

Read More

Aug 11, 2022

Veracyte Appoints Eliav Barr, M.D., to Its Board of Directors

Read More

Aug 02, 2022

Veracyte Announces Second Quarter 2022 Financial Results

Read More

Jul 20, 2022

Veracyte Announces New Clinical Validation Data for RNA Sequencing-Based Afirma Medullary Thyroid Cancer Classifier Published in Thyroid

Read More

Jul 14, 2022

Veracyte to Release Second Quarter 2022 Financial Results on August 2, 2022

Read More

Jul 13, 2022

New Data Published in PLOS ONE Validate the Clinical Performance of Veracyte’s Percepta Genomic Sequencing Classifier in Lung Cancer Diagnosis

Read More

Jun 27, 2022

Veracyte Named a San Francisco “Bay Area Top Workplace” For Ninth Consecutive Year

Read More